MONOTHERAPY WITH PIPERACILLIN/TAZOBACTAM VERSUS CEFEPIME AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC CANCER PATIENTS: A Randomized Comparison-Reference-Cited by-同舟云学术

MONOTHERAPY WITH PIPERACILLIN/TAZOBACTAM VERSUS CEFEPIME AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC CANCER PATIENTS: A Randomized Comparison

Published:2006-01 Issue:3 Volume:23 Page:177-186
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Corapcioglu Funda,Sarper Nazan,Zengin Emine

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.1080/08880010500506370

Reference31 articles.

1. 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

2. Italian Guidelines for the Management of Infectious Complications in Pediatric Oncology: Empirical Antimicrobial Therapy of Febrile Neutropenia

3. Empirical antibiotic therapy in neutropenic cancer patients

4. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors*

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience;The Egyptian Journal of Internal Medicine;2022-08-19

2. The role of cytokine and its relation to depression and infection complications in pediatric cancer;Iranian Journal of Pediatric Hematology & Oncology;2022-07-16

3. Quantum Computational Investigation of (E)-1-(4-methoxyphenyl)-5-methyl-N′-(3-phenoxybenzylidene)-1H-1,2,3-triazole-4-carbohydrazide;Molecules;2022-03-28

4. From “More is Better” to “Less is More”: A Commentary on Antimicrobial Use in Pediatric Oncology;Journal of the Pediatric Infectious Diseases Society;2022-01-31

5. Comparative efficacy and safety of antipseudomonal β-lactams for pediatric febrile neutropenia;Medicine;2021-12-17